|
|
Adrenaline group n = 35 |
Levosimendan group n = 28 |
X2/t |
P-value |
| Age |
51.45 ± 4.37 |
52.08 ± 5.12 |
0.527 |
0.600 |
| Sex |
|
|
|
|
| Female |
5 |
7 |
1.158 |
0.282 |
| Male |
30 |
21 |
||
| BMI |
25.5 ± 4.16 |
26.12 ± 5.31 |
0.520 |
0.605 |
| Weight (kg) |
73.4 ± 13.71 |
72.78 ± 11.7 |
0.190 |
0.849 |
| Height (cm) |
169.1 ± 8.55 |
168.56 ± 7.62 |
0.261 |
0.794 |
| DM |
19 |
12 |
0.813 |
0.367 |
| Systemic hypertension |
19 |
15 |
0.003 |
0.955 |
| NYHA I |
2 |
2 |
0.053 |
0.817 |
| NYHA II |
10 |
8 |
0.000 |
1.000 |
| NYHA III |
12 |
11 |
0.168 |
0.682 |
| NYHA IV |
11 |
7 |
0.315 |
0.575 |
| Angina |
5 |
4 |
0.000 |
1.000 |
| Previous recent MI |
10 |
8 |
0.000 |
1.000 |
| EuroSCORE (range 1.11 - 6.34) |
3.34 ± 1.26 |
3.15 ± 1.42 |
0.562 |
0.576 |
| EF (range 25 - 39)% |
29.45 ± 3.75 |
30.67 ± 4.28 |
1.628 |
0.109 |
| ESD (range 3.5 - 5.5) cm |
4.2 ± 1.14 |
3.95 ± 1.45 |
0.766 |
0.446 |
| EDD (range 4.2 - 6.5) cm |
5.13 ± 1.22 |
5.07 ± 1.36 |
0.184 |
0.854 |
| Left main disease |
5 |
5 |
0.149 |
0.700 |
| Preoperative IABP |
6 |
5 |
0.006 |
0.941 |
| Preoperative inotropes |
0 |
0 |
0.000 |
1.000 |
| Total bypass (range 70 - 120) min |
94.23 ± 5.67 |
95.12 ± 4.84 |
0.660 |
0.512 |
| ACC time (range 45 - 85) min |
68.37 ± 6.69 |
70.08 ± 5.66 |
1.078 |
0.285 |
| Arterial grafts |
1 |
1 |
0.026 |
0.872 |
| Venous grafts (range 1 - 3) |
1.8 ± 0.67 |
1.94 ± 0.43 |
0.958 |
0.342 |
| Total grafts (range 2 - 4) |
2.87 ± 1.01 |
3.12 ± 0.45 |
1.215 |
0.228 |
| Postoperative AF |
9 |
7 |
0.004 |
0.948 |
| Postoperative ventricular arrhythmia |
2 |
1 |
0.158 |
0.691 |
| Need for postoperative IABP |
4 |
1 |
1.314 |
0.252 |
| Need for inotropes > 48 hours |
10 |
13 |
2.140 |
0.144 |
| Need for readministration of inotropes |
7 |
3 |
1.004 |
0.316 |
| Need for reintubation |
4 |
1 |
1.314 |
0.252 |
| Use of adjuvant adrenaline |
Not applicable |
20 |
- |
- |